Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2013

Jul 15, 2013

34999_dirs_2013-07-15_8e13addb-a680-4714-9691-98cc2fe38909.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2013-07-15

Reporting Person: Leventhal Mark S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-07-15 Common Stock, par value $0.0005 A 5490 Acquired 275685 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.0005 180000 Indirect

Footnotes

F1: These restricted shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.

F2: The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.